Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity

Belgin Sever; Cüneyt Türkeş; Yeliz Demir; Khaled M. Elamin; Wadah Osman; Kübra Oral; Selenay Akıncı Genç; Zerrin Cantürk; Takuya Masunaga; Naoki Kishimoto; Shogo Misumi; Masami Otsuka; Mikako Fujita; Halil I. Ciftci

doi:10.3390/ph19010050

Yayın:
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity

Tarih

2025-12-25

Yazarlar

Anahtar kelimeler

In silico, Jurkat cells, A549 cell, In vitro, Apoptosis, Epidermal growth factor receptor, Aldose reductase, Docking (animal), EGFR inhibitors

URI

https://hdl.handle.net/11421/38509
https://doi.org/10.3390/ph19010050

Koleksiyonlar

Publications

Tam öğe sayfası

Yayın:
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity

Tarih

Yazarlar

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayımcı

Araştırma Projeleri

Organizasyon Birimleri

Dergi Sayısı

Özet

Açıklama

Anahtar kelimeler

Alıntı

URI

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By

Yayın: Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity

Tarih

Yazarlar

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayımcı

Araştırma Projeleri

Organizasyon Birimleri

Dergi Sayısı

Özet

Açıklama

Anahtar kelimeler

Alıntı

URI

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By

Yayın:
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity